Anterpreet Neki, M.D.
Associate Physician Diplomate
To see if Anterpreet Neki is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
UC Davis Medical Group - Placer Center for Health
Oncology Clinic and Infusion Center
550 West Ranch View Drive
Rocklin, CA 95765
Additional Numbers
Phone
Philosophy of Care
Dr. Neki believes that every patient needs to be treated with the same involvement, level of care, and compassion as a family member.
Clinical Interests
Dr. Neki is a medical oncologist/hematologist offering care for adults with lung cancer, head and neck cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, pancreatic cancer, hepato-biliary cancer, melanoma, chronic leukemias, multiple myeloma and anemias.
Research/Academic Interests
Dr. Neki has been involved in lung cancer and head/neck cancer research.
Division
Hematology and Oncology
Center/Program Affiliation
Undergraduate School
M.B.B.S., Maulana Azad Medical College, New Delhi India 1985
Medical School
Jr. Resident, GB Pant Hospital, New Delhi India 1985
Other School
House Surgeon, Ophthalmology, RP Center, New Delhi India 1987
Residency
Resident, Georgetown University Medical Center, Washington D.C. 1993-1996
Fellowship
Hematology/Medical Oncology, Ohio State University, Columbus OH 1999-2000
Fellowship
Hematology/Medical Oncology, Department of Internal Medicine, Ohio State University Medical Center, Columbus OH 1996-1999
Faculty Advancement, Mentoring and Engagement Certification at Faculty Leadership Institute, Ohio State University,
Dzienis M, MD1; Cundom J, MD2; Fuentes CS, MD3; Spreafico A, MD4; Nordlinger MJ, MD5; Pastor AV, MD6; Alesi E, MD7; Neki A, MD8; Fung AS, MD9; Figueiredo Lima IP, MD10; Oppelt P, MD11; Felicio da Cunha Junior G, MD12; Burtness B, MD13; Franke FA, MD14; Tseng JE, MD15; Joshi A, MD16; McCarthy J, MD17; Swaby R, MD18*; Sidi Y, PhD18; Gumuscu B, MD18; Naicker N, MD19; de Castro Jr G, PhD20 Pembrolizumab plus carboplatin and paclitaxel as first-line therapy for recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-B10): a single-arm phase 4 trial, (manuscript, pending publication 2024)
Barney CL, Walston S, Zamora P, Nolan N, Virginia M. Clinical Outcomes and Prognostic Factors in Cisplatin versus Cetuximab Chemoradiation for Locally Advanced p16 Positive Oropharyngeal Cancer
Neki A, Rupert R, Savvides P, Agrawal A, Old M, Ozer E, Carrau R, Kang S, Rocco J, Teknos T, Grecula JC, Wobb J, Mitchell D, Blakaj D, Bhatt AD. Diavolitsis, Oral Oncology, Apr 2018; vol 79, 9-14
Kindwall-Keller T, Otterson GA, Young D, Neki AS, Criswell T, Nuovo G, Soong R, Diasio R, Villalona-Calero MA. Phase II evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer. Clin Cancer Res. 2005 Mar 1:11(5):1870-6. IF: 7.742, ISSN: 1078-0432, PMID: 15756012
Neki AS. Hallermann-Streiff Syndrome: A Case Report from India. Ind J Ophthal. 1993 Jul; 41(2):83-4. IF: 1.019, ISSN: 0301-4738, PMID: 8262609
Neki AS. Fluphenazine induced welding arc maculopathy. The British Journal of Ophthalmology. 1992 Apr; 76(4): 255. IF: 2.902, ISSN: 0007-1161, PMID: 1390502, PMCID: 504246
Neki AS, Sharma A. Ipsilateral Coat's reaction in the eye of a child with en coup de sabre morphoea--a case report. Indian J of Ophth. 1992 Jan; 40(4): 115-6, IF: 1.019, ISSN: 0301-4738, PMID: 1300302
Neki AS. Effect of Section Technique and Number of Sutures on Surgically Induced Change in Corneal Astigmatism, Thesis for M.S. Opthal. Nagpur University, 1990.